α-PVP对人类的急性药理作用:一种自然主义的观察性研究
Georgina De la Rosa1,2, Esther Papaseit1,2, Olga Hladun1,2
1Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Frontiers in pharmacology
|July 17, 2025
概括
阿尔法-pyrrolidinopentiophenone (α-PVP) 是一种具有刺激作用的合成阴. 这项研究评估了它对人类的急性影响和滥用潜力,发现它具有类似可卡因的精神刺激和同情性质.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心理药理学 心理药理学
- 神经科学是一个神经科学.
背景情况:
- 阿尔法-pyrrolidinopentiophenone (α-PVP) 是一个合成的甲基类比的pyrovalerone.
- 它的药理作用和滥用潜力尚未得到充分研究.
- 它表现出类似于MDPV和可卡因的精神刺激性质.
研究的目的:
- 评估α-PVP对人类的急性药理作用.
- 评估内注射α-PVP的滥用潜力.
- 为了将α-PVP的效果与已知的精神兴奋剂进行比较.
主要方法:
- 在自然环境中进行的一项非受控的观察研究.
- 九名有精神兴奋剂使用史的参与者自行注射10mg或20mg的α-PVP鼻内.
- 在5小时内测量了生理学 (血压,心率,温度) 和主观效应.
主要成果:
- 鼻腔内注射α-PVP导致血压和心率急剧增加,在40分钟达到峰值.
- 主观效应,包括精神刺激和同情体验的经验,具有快速发作.
- 这些效应在服用后3到5小时内消失.
结论:
- α-PVP表现出与可卡因相当的显著精神刺激性质.
- 这种药物也表现出同情效应,类似于MDMA和其他甲基.
- 需要进一步的研究来充分了解α-PVP的药理学和滥用潜力.
更多相关视频
相关概念视频
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
988
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
988
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
302
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
302


